Kirkwood JM - Search Results

1

Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma.

Sznol M, Ferrucci PF, Hogg D, Atkins MB, Wolter P, Guidoboni M, Lebbé C, Kirkwood JM, Schachter J, Daniels GA, Hassel J, Cebon J, Gerritsen W, Atkinson V, Thomas L, McCaffrey J, Power D, Walker D, Bhore R, Jiang J, Hodi FS, Wolchok JD. Sznol M, et al. Among authors: kirkwood jm. J Clin Oncol. 2017 Dec 1;35(34):3815-3822. doi: 10.1200/JCO.2016.72.1167. Epub 2017 Sep 15. J Clin Oncol. 2017. PMID: 28915085

2

Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study.

Wadler S, Lembersky B, Atkins M, Kirkwood J, Petrelli N. Wadler S, et al. J Clin Oncol. 1991 Oct;9(10):1806-10. doi: 10.1200/JCO.1991.9.10.1806. J Clin Oncol. 1991. PMID: 1919631 Clinical Trial.

3

Studies of interferons in the therapy of melanoma.

Kirkwood JM. Kirkwood JM. Semin Oncol. 1991 Oct;18(5 Suppl 7):83-90. Semin Oncol. 1991. PMID: 1948134 Review.

4

In vivo biological response to recombinant interferon-gamma during a phase I dose-response trial in patients with metastatic melanoma.

Kirkwood JM, Ernstoff MS, Trautman T, Hebert G, Nishida Y, Davis CA, Balzer J, Reich S, Schindler J, Rudnick SA. Kirkwood JM, et al. J Clin Oncol. 1990 Jun;8(6):1070-82. doi: 10.1200/JCO.1990.8.6.1070. J Clin Oncol. 1990. PMID: 2112184 Clinical Trial.

5

A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.

Ernstoff MS, Nair S, Bahnson RR, Miketic LM, Banner B, Gooding W, Day R, Whiteside T, Hakala T, Kirkwood JM. Ernstoff MS, et al. Among authors: kirkwood jm. J Clin Oncol. 1990 Oct;8(10):1637-49. doi: 10.1200/JCO.1990.8.10.1637. J Clin Oncol. 1990. PMID: 2120392

6

A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma.

Ernstoff MS, Trautman T, Davis CA, Reich SD, Witman P, Balser J, Rudnick S, Kirkwood JM. Ernstoff MS, et al. Among authors: kirkwood jm. J Clin Oncol. 1987 Nov;5(11):1804-10. doi: 10.1200/JCO.1987.5.11.1804. J Clin Oncol. 1987. PMID: 3119786 Clinical Trial.

7

Interferons in the therapy of solid tumors.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. Among authors: kirkwood jm. Oncology. 1994 Mar-Apr;51(2):129-36. doi: 10.1159/000227327. Oncology. 1994. PMID: 7515168 Review.

8

Systemic therapy of melanoma.

Kirkwood JM. Kirkwood JM. Curr Opin Oncol. 1994 Mar;6(2):204-11. doi: 10.1097/00001622-199403000-00014. Curr Opin Oncol. 1994. PMID: 8011698 Review.

9

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Kirkwood JM, et al. J Clin Oncol. 1996 Jan;14(1):7-17. doi: 10.1200/JCO.1996.14.1.7. J Clin Oncol. 1996. PMID: 8558223 Corrected and republished. Clinical Trial.

10

Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292.

Sparano JA, Lipsitz S, Wadler S, Hansen R, Bushunow PW, Kirkwood J, Flynn PJ, Dutcher JP, Benson AB. Sparano JA, et al. Am J Clin Oncol. 1996 Dec;19(6):546-51. doi: 10.1097/00000421-199612000-00002. Am J Clin Oncol. 1996. PMID: 8931668 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

600 results

Search Page